Esperion Therapeutis.Inc. buy El_Zocko
Start price
29.09.15
/
50%
€20.64
Target price
20.10.16
€35.00
Performance (%)
-47.70%
End price
20.10.16
€10.79
Summary
This prediction ended on 20.10.16 with a price of €10.79. The BUY prediction by El_Zocko for Esperion Therapeutis.Inc. performed very badly with a performance of -47.70%. El_Zocko has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Esperion Therapeutis.Inc. | 6.160% | 6.160% | 61.002% | -46.343% |
| iShares Core DAX® | 0,46 % | -1,53 % | 9,99 % | 57,24 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % | -0,88 % | 77,24 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % | 30,03 % | 65,69 % |
| iShares S&P 500 | -1,76 % | -3,82 % | -0,21 % | 53,47 % |
Comments by El_Zocko for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Schlimmer geht nimmer?
Hoffen wir es!!
(Laufzeit überschritten)